Tag Archives: Cambridge

Takeda Joins the R&D Migration to Boston

Posted on June 5, 2015 by Alexander Szewczak

From Fierce Biotech, news that the “unending game of global reorganization in biopharma R&D is continuing” with a new move by Takeda to close several vaccine operations around the U.S. in order to concentrate R&D in “the hot Boston/Cambridge, MA hub“

Posted in Biotech, Boston-Cambridge, Pharmaceutical Industry | Tagged , , , | Leave a comment

The New Geography of Innovation

Posted on September 9, 2014 by Alexander Szewczak

A dramatic shift in the geography of innovation is underway, according to a new report authored by Bruce Katz and Julie Wagner of the Brookings Institute, and Kendall Square is the poster child for the paradigm.  Bruce and Tim Row of the … Continue reading →

Posted in Boston-Cambridge, Innovation | Tagged , , , | 1 Comment

Boston edges out Cambridge for new technology firms

Posted on April 6, 2014 by Alexander Szewczak

In a somewhat surprising development, Boston actually had more venture capital deals than Cambridge in 2013.  Ninety-seven deals were signed in Boston, vs. 78 in Cambridge.  Cambridge does still hold a commanding lead in the dollar amount, however, with total funding … Continue reading →

Posted in Innovation | Tagged , , , | Leave a comment

Venture Funding of Biotech is VERY Concentrated… and Very Limited

Posted on March 9, 2014 by Alexander Szewczak

Fierce Biotech has released their latest analysis of venture capital funding of biotech in the U.S. last year, broken down by metropolitan area: Source: http://www.fiercebiotech.com/story/top-15-cities-biotech-venture-funding/2014-03-06 San Francisco is back out in front, edging out Boston-Cambridge.  After San Diego and Washington, funding … Continue reading →

Posted in Biotech, Innovation, Research | Tagged , , , , , , | Leave a comment